http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2243576-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-968
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-974
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-703
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
filingDate 1997-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fcf353d60e2acb6bd932c1c7876fa0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db707a36399ce224a719595669d91e68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_712ee4f055ab234ac8419f878c7fa166
publicationDate 1998-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2243576-A1
titleOfInvention Process of determining the efficacy of drug treatment in hiv infected subjects
abstract The present invention provides a process for determining the efficacy of anti-viral therapy in an HIV-infected subject receiving such therapy. The process includes the steps of a) detecting the level of transcriptionally active HIV in monocytes of the subject at a plurality of different times, b) comparing the detected HIV levels, and c) correlating changes in the detected HIV levels over time with the therapy. The process can be used to monitor the efficacy of treatment with any anti-HIV agent such as AZT, 3TC, DDc, Indivar, or Saquinavir. Decreases in HIV levels over time indicate an efficacious treatment. Increases in detected HIV levels over time indicate resistance to treatment.
priorityDate 1996-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID494186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449264930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12620
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID200103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520973
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25320183
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398599
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID744399
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID36054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411621736
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID554167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID114461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419568502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419563002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65091
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100126739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553058

Total number of triples: 51.